Publication | Closed Access

Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study

Cell TherapyPancreatic CancerPhase I/ii StudyMedicineTumor TargetingCancer TreatmentRadiation OncologyOncologyCell BiologyTumor MicroenvironmentCancer ResearchGene Construct